What’s new in ‘22 for improving safe use of anticoagulants: special focus on the direct oral anticoagulants (DOACs)
About
Since the first approval in 2010, direct oral anticoagulants (DOACs) have emerged as leading therapeutic alternatives that provide both clinicians and patients with more effective, safe, and convenient treatment options in thromboembolic settings. With the expanding role of DOACs, clinicians are faced with increasingly complex decisions relating to appropriate agent, duration of treatment, and use in special populations. Content covered in this education session will include anticoagulation stewardship and anticoagulation safety, latest literature, published best practices, reversal, peri procedural management and how Sanford Health manages a large anticoagulant service.
Objectives
- Describe which anticoagulants are most commonly implicated for harms caused by medications
- Identify practices that have been shown to improve safe use of DOACs
- Discuss implementation practices to improve anticoagulation reversal and periprocedural management
Keynote speaker
Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP, program director for anticoagulation services, Sanford USD Medical Center
Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP is the program director for anticoagulation services at Sanford USD Medical Center in Sioux Falls, South Dakota. He is also a clinical associate professor, Department of Internal Medicine, at the University of South Dakota Sanford School of Medicine. Dr. Gulseth received his Doctor of Pharmacy degree in 1999 from North Dakota State University in Fargo, North Dakota. He completed residency training at United Hospital in St. Paul, Minnesota.
Dr. Gulseth is author and editor of Managing Anticoagulation Patients in the Hospital: The Inpatient Anticoagulation Service, published in 2007 by the American Society of Health-System Pharmacists (ASHP). He is a co-editor and author of Anticoagulation Therapy: A Clinical Practice Guide, 2nd edition published in 2018, by the ASHP.
Panelists:
Michael P. Gulseth, PharmD., BCPS, FMSHP, FASHP, Sanford USD Medical Center
Abby Hendricks, PharmD, BCPS, internal medicine clinical pharmacist, Mayo Clinic– Rochester
Ondrea Levos, PharmD, clinical pharmacy manager, ambulatory care services, M Health Fairview
Shawna Sprengeler, PharmD, senior pharmacist, Sanford Tracy Medical Center
Facilitators:
Jessica Swearingen, PharmD, BCPS, DPLA, PGY2 Health System Pharmacy Administration and Leadership Residency program coordinator, pharmacy manager, Allina Health
Matthew Lillyblad, PharmD, BCCCP, BCCP, PGY2 Cardiology Residency Program director; clinical pharmacy coordinator for cardiology and critical care, Allina Health
Recommended to attend
Pharmacists, emergency medicine professionals, physicians, nurses, and quality improvement teams.
Continuing education
The program has been designed to meet the Minnesota Board of Nursing continuing education requirements for a total of two contact hours.
Fee
- $25 per person for MHA member hospitals and health systems and MSHP members*
- $50 per person for associate members
- $75 per person for nonmembers
* Members of Minnesota Society of Health-System Pharmacists (MSHP) should contact Kimberley Huntington for next steps to receive the member discount
Registration deadline
Please register by noon on the day before the webinar to ensure timely delivery of access instructions.
Approximately four business days before the web conference, you will receive an email that contains instructions on how to connect. Advance registration is required to ensure delivery of instructional materials.
If you do not receive an email prior to the program with web conference details, please Contact Us to confirm your registration.